nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—ACE—vein—testicular cancer	0.047	0.466	CbGeAlD
Fosinopril—ACE—embryo—testicular cancer	0.00889	0.0883	CbGeAlD
Fosinopril—ACE—seminal vesicle—testicular cancer	0.00835	0.0829	CbGeAlD
Fosinopril—SLC15A2—seminal vesicle—testicular cancer	0.00728	0.0723	CbGeAlD
Fosinopril—ACE—gonad—testicular cancer	0.00603	0.0599	CbGeAlD
Fosinopril—ACE—female gonad—testicular cancer	0.0049	0.0487	CbGeAlD
Fosinopril—ACE—testis—testicular cancer	0.00435	0.0432	CbGeAlD
Fosinopril—SLC15A2—female gonad—testicular cancer	0.00428	0.0424	CbGeAlD
Fosinopril—SLC15A2—testis—testicular cancer	0.00379	0.0376	CbGeAlD
Fosinopril—ACE—lymph node—testicular cancer	0.00315	0.0313	CbGeAlD
Fosinopril—SLC15A2—lymph node—testicular cancer	0.00275	0.0273	CbGeAlD
Fosinopril—Rash—Dactinomycin—testicular cancer	0.000568	0.000632	CcSEcCtD
Fosinopril—Decreased appetite—Etoposide—testicular cancer	0.000567	0.000631	CcSEcCtD
Fosinopril—Diarrhoea—Ifosfamide—testicular cancer	0.000565	0.000628	CcSEcCtD
Fosinopril—Pancytopenia—Doxorubicin—testicular cancer	0.000565	0.000628	CcSEcCtD
Fosinopril—Renal failure—Epirubicin—testicular cancer	0.000564	0.000627	CcSEcCtD
Fosinopril—Body temperature increased—Cisplatin—testicular cancer	0.000563	0.000626	CcSEcCtD
Fosinopril—Fatigue—Etoposide—testicular cancer	0.000562	0.000625	CcSEcCtD
Fosinopril—Neuropathy peripheral—Epirubicin—testicular cancer	0.000562	0.000625	CcSEcCtD
Fosinopril—Jaundice—Epirubicin—testicular cancer	0.000559	0.000621	CcSEcCtD
Fosinopril—Constipation—Etoposide—testicular cancer	0.000558	0.00062	CcSEcCtD
Fosinopril—Pain—Etoposide—testicular cancer	0.000558	0.00062	CcSEcCtD
Fosinopril—Neutropenia—Doxorubicin—testicular cancer	0.000556	0.000619	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000553	0.000615	CcSEcCtD
Fosinopril—Haemoglobin—Methotrexate—testicular cancer	0.000553	0.000615	CcSEcCtD
Fosinopril—Haemorrhage—Methotrexate—testicular cancer	0.00055	0.000612	CcSEcCtD
Fosinopril—Hepatitis—Methotrexate—testicular cancer	0.00055	0.000612	CcSEcCtD
Fosinopril—Pollakiuria—Doxorubicin—testicular cancer	0.00055	0.000611	CcSEcCtD
Fosinopril—Dizziness—Ifosfamide—testicular cancer	0.000546	0.000607	CcSEcCtD
Fosinopril—Pharyngitis—Methotrexate—testicular cancer	0.000546	0.000607	CcSEcCtD
Fosinopril—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000543	0.000604	CcSEcCtD
Fosinopril—Weight increased—Doxorubicin—testicular cancer	0.000541	0.000602	CcSEcCtD
Fosinopril—Epistaxis—Epirubicin—testicular cancer	0.000541	0.000601	CcSEcCtD
Fosinopril—Weight decreased—Doxorubicin—testicular cancer	0.000538	0.000599	CcSEcCtD
Fosinopril—Sinusitis—Epirubicin—testicular cancer	0.000538	0.000598	CcSEcCtD
Fosinopril—Feeling abnormal—Etoposide—testicular cancer	0.000538	0.000598	CcSEcCtD
Fosinopril—Nausea—Dactinomycin—testicular cancer	0.000535	0.000595	CcSEcCtD
Fosinopril—Agranulocytosis—Epirubicin—testicular cancer	0.000535	0.000595	CcSEcCtD
Fosinopril—Pneumonia—Doxorubicin—testicular cancer	0.000534	0.000593	CcSEcCtD
Fosinopril—Gastrointestinal pain—Etoposide—testicular cancer	0.000533	0.000593	CcSEcCtD
Fosinopril—Drowsiness—Doxorubicin—testicular cancer	0.00053	0.00059	CcSEcCtD
Fosinopril—Visual impairment—Methotrexate—testicular cancer	0.00053	0.000589	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000526	0.000585	CcSEcCtD
Fosinopril—Vomiting—Ifosfamide—testicular cancer	0.000525	0.000584	CcSEcCtD
Fosinopril—Hypersensitivity—Cisplatin—testicular cancer	0.000525	0.000583	CcSEcCtD
Fosinopril—Bradycardia—Epirubicin—testicular cancer	0.000524	0.000583	CcSEcCtD
Fosinopril—Renal failure—Doxorubicin—testicular cancer	0.000521	0.00058	CcSEcCtD
Fosinopril—Rash—Ifosfamide—testicular cancer	0.000521	0.000579	CcSEcCtD
Fosinopril—Dermatitis—Ifosfamide—testicular cancer	0.00052	0.000579	CcSEcCtD
Fosinopril—Erythema multiforme—Methotrexate—testicular cancer	0.00052	0.000578	CcSEcCtD
Fosinopril—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00052	0.000578	CcSEcCtD
Fosinopril—Urticaria—Etoposide—testicular cancer	0.000518	0.000576	CcSEcCtD
Fosinopril—Haemoglobin—Epirubicin—testicular cancer	0.000517	0.000575	CcSEcCtD
Fosinopril—Jaundice—Doxorubicin—testicular cancer	0.000517	0.000575	CcSEcCtD
Fosinopril—Rhinitis—Epirubicin—testicular cancer	0.000516	0.000574	CcSEcCtD
Fosinopril—Abdominal pain—Etoposide—testicular cancer	0.000516	0.000573	CcSEcCtD
Fosinopril—Body temperature increased—Etoposide—testicular cancer	0.000516	0.000573	CcSEcCtD
Fosinopril—Haemorrhage—Epirubicin—testicular cancer	0.000515	0.000572	CcSEcCtD
Fosinopril—Hepatitis—Epirubicin—testicular cancer	0.000515	0.000572	CcSEcCtD
Fosinopril—Tinnitus—Methotrexate—testicular cancer	0.000513	0.00057	CcSEcCtD
Fosinopril—Hypoaesthesia—Epirubicin—testicular cancer	0.000512	0.000569	CcSEcCtD
Fosinopril—Asthenia—Cisplatin—testicular cancer	0.000511	0.000568	CcSEcCtD
Fosinopril—Pharyngitis—Epirubicin—testicular cancer	0.000511	0.000568	CcSEcCtD
Fosinopril—Oedema peripheral—Epirubicin—testicular cancer	0.000507	0.000564	CcSEcCtD
Fosinopril—Epistaxis—Doxorubicin—testicular cancer	0.0005	0.000556	CcSEcCtD
Fosinopril—Sinusitis—Doxorubicin—testicular cancer	0.000498	0.000553	CcSEcCtD
Fosinopril—Visual impairment—Epirubicin—testicular cancer	0.000496	0.000552	CcSEcCtD
Fosinopril—Agranulocytosis—Doxorubicin—testicular cancer	0.000495	0.00055	CcSEcCtD
Fosinopril—Chills—Methotrexate—testicular cancer	0.000493	0.000549	CcSEcCtD
Fosinopril—Nausea—Ifosfamide—testicular cancer	0.000491	0.000546	CcSEcCtD
Fosinopril—Diarrhoea—Cisplatin—testicular cancer	0.000487	0.000542	CcSEcCtD
Fosinopril—Erythema multiforme—Epirubicin—testicular cancer	0.000487	0.000541	CcSEcCtD
Fosinopril—Bradycardia—Doxorubicin—testicular cancer	0.000485	0.000539	CcSEcCtD
Fosinopril—Hypersensitivity—Etoposide—testicular cancer	0.000481	0.000534	CcSEcCtD
Fosinopril—Tinnitus—Epirubicin—testicular cancer	0.00048	0.000534	CcSEcCtD
Fosinopril—Haemoglobin—Doxorubicin—testicular cancer	0.000479	0.000532	CcSEcCtD
Fosinopril—Flushing—Epirubicin—testicular cancer	0.000478	0.000531	CcSEcCtD
Fosinopril—Rhinitis—Doxorubicin—testicular cancer	0.000477	0.000531	CcSEcCtD
Fosinopril—Haemorrhage—Doxorubicin—testicular cancer	0.000476	0.00053	CcSEcCtD
Fosinopril—Hepatitis—Doxorubicin—testicular cancer	0.000476	0.00053	CcSEcCtD
Fosinopril—Hypoaesthesia—Doxorubicin—testicular cancer	0.000474	0.000527	CcSEcCtD
Fosinopril—Pharyngitis—Doxorubicin—testicular cancer	0.000473	0.000526	CcSEcCtD
Fosinopril—Oedema peripheral—Doxorubicin—testicular cancer	0.000469	0.000522	CcSEcCtD
Fosinopril—Dysgeusia—Methotrexate—testicular cancer	0.000469	0.000521	CcSEcCtD
Fosinopril—Asthenia—Etoposide—testicular cancer	0.000468	0.00052	CcSEcCtD
Fosinopril—Chills—Epirubicin—testicular cancer	0.000462	0.000514	CcSEcCtD
Fosinopril—Pruritus—Etoposide—testicular cancer	0.000461	0.000513	CcSEcCtD
Fosinopril—Arrhythmia—Epirubicin—testicular cancer	0.00046	0.000511	CcSEcCtD
Fosinopril—Visual impairment—Doxorubicin—testicular cancer	0.000459	0.00051	CcSEcCtD
Fosinopril—Vomiting—Cisplatin—testicular cancer	0.000453	0.000503	CcSEcCtD
Fosinopril—Vision blurred—Methotrexate—testicular cancer	0.000451	0.000502	CcSEcCtD
Fosinopril—Erythema multiforme—Doxorubicin—testicular cancer	0.00045	0.000501	CcSEcCtD
Fosinopril—Rash—Cisplatin—testicular cancer	0.000449	0.000499	CcSEcCtD
Fosinopril—Dermatitis—Cisplatin—testicular cancer	0.000449	0.000499	CcSEcCtD
Fosinopril—Diarrhoea—Etoposide—testicular cancer	0.000446	0.000496	CcSEcCtD
Fosinopril—Ill-defined disorder—Methotrexate—testicular cancer	0.000444	0.000494	CcSEcCtD
Fosinopril—Tinnitus—Doxorubicin—testicular cancer	0.000444	0.000494	CcSEcCtD
Fosinopril—Anaemia—Methotrexate—testicular cancer	0.000442	0.000492	CcSEcCtD
Fosinopril—Flushing—Doxorubicin—testicular cancer	0.000442	0.000491	CcSEcCtD
Fosinopril—Flatulence—Epirubicin—testicular cancer	0.000441	0.000491	CcSEcCtD
Fosinopril—Tension—Epirubicin—testicular cancer	0.00044	0.000489	CcSEcCtD
Fosinopril—Dysgeusia—Epirubicin—testicular cancer	0.000439	0.000488	CcSEcCtD
Fosinopril—Nervousness—Epirubicin—testicular cancer	0.000435	0.000484	CcSEcCtD
Fosinopril—Malaise—Methotrexate—testicular cancer	0.000432	0.00048	CcSEcCtD
Fosinopril—Dizziness—Etoposide—testicular cancer	0.000431	0.00048	CcSEcCtD
Fosinopril—Muscle spasms—Epirubicin—testicular cancer	0.000431	0.000479	CcSEcCtD
Fosinopril—Vertigo—Methotrexate—testicular cancer	0.00043	0.000478	CcSEcCtD
Fosinopril—Leukopenia—Methotrexate—testicular cancer	0.000429	0.000477	CcSEcCtD
Fosinopril—Chills—Doxorubicin—testicular cancer	0.000427	0.000475	CcSEcCtD
Fosinopril—Arrhythmia—Doxorubicin—testicular cancer	0.000425	0.000473	CcSEcCtD
Fosinopril—Nausea—Cisplatin—testicular cancer	0.000423	0.00047	CcSEcCtD
Fosinopril—Vision blurred—Epirubicin—testicular cancer	0.000422	0.00047	CcSEcCtD
Fosinopril—Cough—Methotrexate—testicular cancer	0.000418	0.000465	CcSEcCtD
Fosinopril—Ill-defined disorder—Epirubicin—testicular cancer	0.000416	0.000462	CcSEcCtD
Fosinopril—Vomiting—Etoposide—testicular cancer	0.000415	0.000461	CcSEcCtD
Fosinopril—Anaemia—Epirubicin—testicular cancer	0.000414	0.00046	CcSEcCtD
Fosinopril—Agitation—Epirubicin—testicular cancer	0.000412	0.000458	CcSEcCtD
Fosinopril—Rash—Etoposide—testicular cancer	0.000411	0.000457	CcSEcCtD
Fosinopril—Dermatitis—Etoposide—testicular cancer	0.000411	0.000457	CcSEcCtD
Fosinopril—Headache—Etoposide—testicular cancer	0.000409	0.000454	CcSEcCtD
Fosinopril—Flatulence—Doxorubicin—testicular cancer	0.000408	0.000454	CcSEcCtD
Fosinopril—Arthralgia—Methotrexate—testicular cancer	0.000408	0.000453	CcSEcCtD
Fosinopril—Myalgia—Methotrexate—testicular cancer	0.000408	0.000453	CcSEcCtD
Fosinopril—Chest pain—Methotrexate—testicular cancer	0.000408	0.000453	CcSEcCtD
Fosinopril—Tension—Doxorubicin—testicular cancer	0.000407	0.000452	CcSEcCtD
Fosinopril—Dysgeusia—Doxorubicin—testicular cancer	0.000406	0.000451	CcSEcCtD
Fosinopril—Malaise—Epirubicin—testicular cancer	0.000404	0.000449	CcSEcCtD
Fosinopril—Discomfort—Methotrexate—testicular cancer	0.000403	0.000448	CcSEcCtD
Fosinopril—Nervousness—Doxorubicin—testicular cancer	0.000403	0.000448	CcSEcCtD
Fosinopril—Vertigo—Epirubicin—testicular cancer	0.000403	0.000448	CcSEcCtD
Fosinopril—Syncope—Epirubicin—testicular cancer	0.000402	0.000447	CcSEcCtD
Fosinopril—Leukopenia—Epirubicin—testicular cancer	0.000401	0.000446	CcSEcCtD
Fosinopril—Muscle spasms—Doxorubicin—testicular cancer	0.000399	0.000443	CcSEcCtD
Fosinopril—Palpitations—Epirubicin—testicular cancer	0.000396	0.00044	CcSEcCtD
Fosinopril—Confusional state—Methotrexate—testicular cancer	0.000394	0.000438	CcSEcCtD
Fosinopril—Loss of consciousness—Epirubicin—testicular cancer	0.000394	0.000438	CcSEcCtD
Fosinopril—Cough—Epirubicin—testicular cancer	0.000391	0.000435	CcSEcCtD
Fosinopril—Anaphylactic shock—Methotrexate—testicular cancer	0.000391	0.000434	CcSEcCtD
Fosinopril—Vision blurred—Doxorubicin—testicular cancer	0.000391	0.000434	CcSEcCtD
Fosinopril—Infection—Methotrexate—testicular cancer	0.000388	0.000432	CcSEcCtD
Fosinopril—Nausea—Etoposide—testicular cancer	0.000387	0.000431	CcSEcCtD
Fosinopril—Hypertension—Epirubicin—testicular cancer	0.000387	0.00043	CcSEcCtD
Fosinopril—Ill-defined disorder—Doxorubicin—testicular cancer	0.000385	0.000428	CcSEcCtD
Fosinopril—Anaemia—Doxorubicin—testicular cancer	0.000383	0.000426	CcSEcCtD
Fosinopril—Thrombocytopenia—Methotrexate—testicular cancer	0.000383	0.000425	CcSEcCtD
Fosinopril—Arthralgia—Epirubicin—testicular cancer	0.000381	0.000424	CcSEcCtD
Fosinopril—Chest pain—Epirubicin—testicular cancer	0.000381	0.000424	CcSEcCtD
Fosinopril—Myalgia—Epirubicin—testicular cancer	0.000381	0.000424	CcSEcCtD
Fosinopril—Agitation—Doxorubicin—testicular cancer	0.000381	0.000424	CcSEcCtD
Fosinopril—Hyperhidrosis—Methotrexate—testicular cancer	0.000378	0.00042	CcSEcCtD
Fosinopril—Discomfort—Epirubicin—testicular cancer	0.000377	0.000419	CcSEcCtD
Fosinopril—Malaise—Doxorubicin—testicular cancer	0.000374	0.000416	CcSEcCtD
Fosinopril—Dry mouth—Epirubicin—testicular cancer	0.000373	0.000415	CcSEcCtD
Fosinopril—Vertigo—Doxorubicin—testicular cancer	0.000372	0.000414	CcSEcCtD
Fosinopril—Anorexia—Methotrexate—testicular cancer	0.000372	0.000414	CcSEcCtD
Fosinopril—Syncope—Doxorubicin—testicular cancer	0.000372	0.000413	CcSEcCtD
Fosinopril—Leukopenia—Doxorubicin—testicular cancer	0.000371	0.000413	CcSEcCtD
Fosinopril—Confusional state—Epirubicin—testicular cancer	0.000369	0.00041	CcSEcCtD
Fosinopril—Palpitations—Doxorubicin—testicular cancer	0.000366	0.000407	CcSEcCtD
Fosinopril—Oedema—Epirubicin—testicular cancer	0.000366	0.000407	CcSEcCtD
Fosinopril—Anaphylactic shock—Epirubicin—testicular cancer	0.000366	0.000407	CcSEcCtD
Fosinopril—Hypotension—Methotrexate—testicular cancer	0.000365	0.000406	CcSEcCtD
Fosinopril—Loss of consciousness—Doxorubicin—testicular cancer	0.000364	0.000405	CcSEcCtD
Fosinopril—Infection—Epirubicin—testicular cancer	0.000363	0.000404	CcSEcCtD
Fosinopril—Cough—Doxorubicin—testicular cancer	0.000362	0.000402	CcSEcCtD
Fosinopril—Shock—Epirubicin—testicular cancer	0.00036	0.0004	CcSEcCtD
Fosinopril—Thrombocytopenia—Epirubicin—testicular cancer	0.000358	0.000398	CcSEcCtD
Fosinopril—Hypertension—Doxorubicin—testicular cancer	0.000358	0.000398	CcSEcCtD
Fosinopril—Tachycardia—Epirubicin—testicular cancer	0.000357	0.000397	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000356	0.000396	CcSEcCtD
Fosinopril—Hyperhidrosis—Epirubicin—testicular cancer	0.000353	0.000393	CcSEcCtD
Fosinopril—Insomnia—Methotrexate—testicular cancer	0.000353	0.000393	CcSEcCtD
Fosinopril—Arthralgia—Doxorubicin—testicular cancer	0.000353	0.000392	CcSEcCtD
Fosinopril—Myalgia—Doxorubicin—testicular cancer	0.000353	0.000392	CcSEcCtD
Fosinopril—Chest pain—Doxorubicin—testicular cancer	0.000353	0.000392	CcSEcCtD
Fosinopril—Paraesthesia—Methotrexate—testicular cancer	0.000351	0.00039	CcSEcCtD
Fosinopril—Discomfort—Doxorubicin—testicular cancer	0.000349	0.000388	CcSEcCtD
Fosinopril—Anorexia—Epirubicin—testicular cancer	0.000349	0.000388	CcSEcCtD
Fosinopril—Dyspnoea—Methotrexate—testicular cancer	0.000348	0.000387	CcSEcCtD
Fosinopril—Somnolence—Methotrexate—testicular cancer	0.000347	0.000386	CcSEcCtD
Fosinopril—Dry mouth—Doxorubicin—testicular cancer	0.000345	0.000384	CcSEcCtD
Fosinopril—Dyspepsia—Methotrexate—testicular cancer	0.000344	0.000382	CcSEcCtD
Fosinopril—Hypotension—Epirubicin—testicular cancer	0.000342	0.00038	CcSEcCtD
Fosinopril—Confusional state—Doxorubicin—testicular cancer	0.000341	0.000379	CcSEcCtD
Fosinopril—Decreased appetite—Methotrexate—testicular cancer	0.00034	0.000378	CcSEcCtD
Fosinopril—Oedema—Doxorubicin—testicular cancer	0.000338	0.000376	CcSEcCtD
Fosinopril—Anaphylactic shock—Doxorubicin—testicular cancer	0.000338	0.000376	CcSEcCtD
Fosinopril—Fatigue—Methotrexate—testicular cancer	0.000337	0.000375	CcSEcCtD
Fosinopril—Infection—Doxorubicin—testicular cancer	0.000336	0.000374	CcSEcCtD
Fosinopril—Pain—Methotrexate—testicular cancer	0.000334	0.000372	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000333	0.00037	CcSEcCtD
Fosinopril—Shock—Doxorubicin—testicular cancer	0.000333	0.00037	CcSEcCtD
Fosinopril—Thrombocytopenia—Doxorubicin—testicular cancer	0.000331	0.000368	CcSEcCtD
Fosinopril—Insomnia—Epirubicin—testicular cancer	0.000331	0.000368	CcSEcCtD
Fosinopril—Tachycardia—Doxorubicin—testicular cancer	0.00033	0.000367	CcSEcCtD
Fosinopril—Paraesthesia—Epirubicin—testicular cancer	0.000328	0.000365	CcSEcCtD
Fosinopril—Hyperhidrosis—Doxorubicin—testicular cancer	0.000327	0.000364	CcSEcCtD
Fosinopril—Dyspnoea—Epirubicin—testicular cancer	0.000326	0.000363	CcSEcCtD
Fosinopril—Somnolence—Epirubicin—testicular cancer	0.000325	0.000361	CcSEcCtD
Fosinopril—Anorexia—Doxorubicin—testicular cancer	0.000322	0.000359	CcSEcCtD
Fosinopril—Feeling abnormal—Methotrexate—testicular cancer	0.000322	0.000358	CcSEcCtD
Fosinopril—Dyspepsia—Epirubicin—testicular cancer	0.000322	0.000358	CcSEcCtD
Fosinopril—Gastrointestinal pain—Methotrexate—testicular cancer	0.000319	0.000355	CcSEcCtD
Fosinopril—Decreased appetite—Epirubicin—testicular cancer	0.000318	0.000353	CcSEcCtD
Fosinopril—Hypotension—Doxorubicin—testicular cancer	0.000316	0.000352	CcSEcCtD
Fosinopril—Fatigue—Epirubicin—testicular cancer	0.000315	0.000351	CcSEcCtD
Fosinopril—Constipation—Epirubicin—testicular cancer	0.000313	0.000348	CcSEcCtD
Fosinopril—Pain—Epirubicin—testicular cancer	0.000313	0.000348	CcSEcCtD
Fosinopril—Urticaria—Methotrexate—testicular cancer	0.00031	0.000345	CcSEcCtD
Fosinopril—Body temperature increased—Methotrexate—testicular cancer	0.000309	0.000343	CcSEcCtD
Fosinopril—Abdominal pain—Methotrexate—testicular cancer	0.000309	0.000343	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000308	0.000343	CcSEcCtD
Fosinopril—Insomnia—Doxorubicin—testicular cancer	0.000306	0.00034	CcSEcCtD
Fosinopril—Paraesthesia—Doxorubicin—testicular cancer	0.000304	0.000338	CcSEcCtD
Fosinopril—Dyspnoea—Doxorubicin—testicular cancer	0.000302	0.000335	CcSEcCtD
Fosinopril—Feeling abnormal—Epirubicin—testicular cancer	0.000301	0.000335	CcSEcCtD
Fosinopril—Somnolence—Doxorubicin—testicular cancer	0.000301	0.000334	CcSEcCtD
Fosinopril—Gastrointestinal pain—Epirubicin—testicular cancer	0.000299	0.000332	CcSEcCtD
Fosinopril—Dyspepsia—Doxorubicin—testicular cancer	0.000298	0.000331	CcSEcCtD
Fosinopril—Decreased appetite—Doxorubicin—testicular cancer	0.000294	0.000327	CcSEcCtD
Fosinopril—Fatigue—Doxorubicin—testicular cancer	0.000292	0.000324	CcSEcCtD
Fosinopril—Urticaria—Epirubicin—testicular cancer	0.00029	0.000323	CcSEcCtD
Fosinopril—Pain—Doxorubicin—testicular cancer	0.000289	0.000322	CcSEcCtD
Fosinopril—Constipation—Doxorubicin—testicular cancer	0.000289	0.000322	CcSEcCtD
Fosinopril—Body temperature increased—Epirubicin—testicular cancer	0.000289	0.000321	CcSEcCtD
Fosinopril—Abdominal pain—Epirubicin—testicular cancer	0.000289	0.000321	CcSEcCtD
Fosinopril—Hypersensitivity—Methotrexate—testicular cancer	0.000288	0.00032	CcSEcCtD
Fosinopril—Asthenia—Methotrexate—testicular cancer	0.00028	0.000312	CcSEcCtD
Fosinopril—Feeling abnormal—Doxorubicin—testicular cancer	0.000279	0.00031	CcSEcCtD
Fosinopril—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000277	0.000308	CcSEcCtD
Fosinopril—Pruritus—Methotrexate—testicular cancer	0.000276	0.000307	CcSEcCtD
Fosinopril—Hypersensitivity—Epirubicin—testicular cancer	0.000269	0.0003	CcSEcCtD
Fosinopril—Urticaria—Doxorubicin—testicular cancer	0.000269	0.000299	CcSEcCtD
Fosinopril—Abdominal pain—Doxorubicin—testicular cancer	0.000267	0.000297	CcSEcCtD
Fosinopril—Body temperature increased—Doxorubicin—testicular cancer	0.000267	0.000297	CcSEcCtD
Fosinopril—Diarrhoea—Methotrexate—testicular cancer	0.000267	0.000297	CcSEcCtD
Fosinopril—Asthenia—Epirubicin—testicular cancer	0.000262	0.000292	CcSEcCtD
Fosinopril—Pruritus—Epirubicin—testicular cancer	0.000259	0.000288	CcSEcCtD
Fosinopril—Dizziness—Methotrexate—testicular cancer	0.000258	0.000287	CcSEcCtD
Fosinopril—Diarrhoea—Epirubicin—testicular cancer	0.00025	0.000278	CcSEcCtD
Fosinopril—Hypersensitivity—Doxorubicin—testicular cancer	0.000249	0.000277	CcSEcCtD
Fosinopril—Vomiting—Methotrexate—testicular cancer	0.000248	0.000276	CcSEcCtD
Fosinopril—Rash—Methotrexate—testicular cancer	0.000246	0.000274	CcSEcCtD
Fosinopril—Dermatitis—Methotrexate—testicular cancer	0.000246	0.000274	CcSEcCtD
Fosinopril—Headache—Methotrexate—testicular cancer	0.000245	0.000272	CcSEcCtD
Fosinopril—Asthenia—Doxorubicin—testicular cancer	0.000243	0.00027	CcSEcCtD
Fosinopril—Dizziness—Epirubicin—testicular cancer	0.000242	0.000269	CcSEcCtD
Fosinopril—Pruritus—Doxorubicin—testicular cancer	0.000239	0.000266	CcSEcCtD
Fosinopril—Vomiting—Epirubicin—testicular cancer	0.000232	0.000259	CcSEcCtD
Fosinopril—Nausea—Methotrexate—testicular cancer	0.000232	0.000258	CcSEcCtD
Fosinopril—Diarrhoea—Doxorubicin—testicular cancer	0.000231	0.000257	CcSEcCtD
Fosinopril—Rash—Epirubicin—testicular cancer	0.000231	0.000256	CcSEcCtD
Fosinopril—Dermatitis—Epirubicin—testicular cancer	0.00023	0.000256	CcSEcCtD
Fosinopril—Headache—Epirubicin—testicular cancer	0.000229	0.000255	CcSEcCtD
Fosinopril—Dizziness—Doxorubicin—testicular cancer	0.000224	0.000249	CcSEcCtD
Fosinopril—Nausea—Epirubicin—testicular cancer	0.000217	0.000242	CcSEcCtD
Fosinopril—Vomiting—Doxorubicin—testicular cancer	0.000215	0.000239	CcSEcCtD
Fosinopril—Rash—Doxorubicin—testicular cancer	0.000213	0.000237	CcSEcCtD
Fosinopril—Dermatitis—Doxorubicin—testicular cancer	0.000213	0.000237	CcSEcCtD
Fosinopril—Headache—Doxorubicin—testicular cancer	0.000212	0.000236	CcSEcCtD
Fosinopril—Nausea—Doxorubicin—testicular cancer	0.000201	0.000223	CcSEcCtD
